Lorraine Aleandri

Dr Lorraine Aleandri is a German Patent Attorney, a European Patent and a US Patent Agent, specialises in oppositions, appeals, freedom-to-operate opinions, litigation. Lorraine’s work focuses on chemistry, physics and engineering, including medical and drug delivery products. 


Year joined: 2019

Qualifications: Ph.D., B.A. Biol. & Chem., (German) Patent Attorney, European Patent Attorney, European Trademark and Design Attorney, US Patent Agent


Dr. Aleandri works in all fields of IP law and her areas of expertise include protection of inventions, oppositions (defensive and offensive), appeals, freedom-to-operate opinions, litigation and due diligence. 


Dr. Aleandri studied Biology and Chemistry at Mercyhurst College in Erie, Pennsylvania graduating with a bachelor degree. She received a Ph.D. from Iowa State University in the field of solid state inorganic chemistry. 

Dr. Aleandri started her career in the field of intellectual property by undertaking Advances Studies in Intellectual Property at the Humboldt University in Berlin, then joining in 1996 the law firm Bardehle, Pagenberg, Dost, Frohwitter, Geissler in Munich as a trainee patent attorney candidate.

Additionally, Dr. Aleandri has a postgraduate Diploma in EU Competition Law from King’s College London, University of London, as well as a Diplôme d’ Université D’Etudies Supérieures sur le Contentieux des Brevets en Europe from Université de Strasbourg.

Recent Work

Dr. Aleandri worked from 2000 to 2014 in the European intellectual property department of a global, diversified technology company headquartered in US, handling IP matters in a number of technology areas including medical devices, medicinal delivery products, materials science, and separation technology.

In 2015 Dr. Aleandri joined the patent law firm Herzog Fiesser and Partner based in Düsseldorf, Munich and Mannheim handing IP matters in diverse technologies including e.g. personal care products, personal safety products, lithium batteries and metallurgy.


Follow us on twitter